Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -61,920 | -140,870 | -3,880 | -950 |
| Depreciation Amortization | 3,660 | 24,800 | 4,560 | 1,080 |
| Other Working Capital | -3,810 | 3,880 | 3,480 | -2,580 |
| Other Operating Activity | 39,940 | 75,090 | -6,120 | -160 |
| Operating Cash Flow | $-22,130 | $-37,100 | $-1,960 | $-2,610 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -910 | -7,440 | -7,010 | -2,190 |
| Net Acquisitions | 0 | 0 | -43,280 | 160 |
| Other Investing Activity | 40 | 3,840 | -3,520 | -640 |
| Investing Cash Flow | $-870 | $-3,600 | $-53,810 | $-2,670 |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | 0 | 0 | 0 | -70 |
| Other Financing Activity | 920 | 1,980 | 46,030 | 95,040 |
| Financing Cash Flow | $920 | $1,980 | $46,030 | $94,970 |
| Exchange Rate Effect | 270 | -40 | 160 | -40 |
| Beginning Cash Position | 41,270 | 80,050 | 89,630 | 0 |
| End Cash Position | 19,460 | 41,270 | 80,050 | 89,630 |
| Net Cash Flow | $-21,810 | $-38,780 | $-9,570 | $89,630 |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,130 | -37,100 | -1,960 | -2,610 |
| Free Cash Flow | -22,130 | -37,100 | -1,960 | -2,610 |